Aptar acquires Nanopharm and Gateway Analytical
Both acquisitions bring complementary, value-added and differentiated analytical, testing and
development services for all stages…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
PharmaLytica 2019 makes debut in Mumbai
PharmaLytica enables the pharmaceutical community to gather current industry trends, innovations and conduct business with…
US FDA finds zero 483 observations and grants NAI to Centaur Pharmaceutical’s Finished Dosage…
In addition to US FDA accreditation, the said facility also conforms to MHRA (UK), TGA (Australia), Health Canada, MCC (South…
IPHEX 2019 Mega Pharma Show opens in Gandhinagar
Gujarat Chief Minister Vijay Rupani invites industry to make investments in pharma sector
ACG Inspection Installs 1,000th Track & Trace Line
ACG’s comprehensive serialization services has been implemented in more than 100 countries around the world
BigBrother Nutra Care organises press con to spread awareness on oral cancer
The company recently held a press conference on the subject of oral cancer, where it unveiled SvarnSaathi, a nutraceutical product…
PM to lead 30,000 yoga enthusiasts on 5th IDY in Ranchi
The ministry of AYUSH has successfully organised several programmes during the last four years in connection with International…
PhoenixMD and WuXi STA achieve clinical trial supply manufacturing milestone for PMD-026
PhoenixMD's lead program, PMD-026, is the first RSK inhibitor built for the treatment of triple-negative breast cancer (TNBC)
CCI imposes Rs 74 cr fine on Himalaya Drug, three others for anti-competitive trade practices
The fair trade regulator held the drug companies responsible for mandating the requirement of obtaining NOC (No Objection…
AstraZeneca’s blood cancer drug meets main goal in late-stage trial
The drug, Calquence, showed meaningful improvement in patients with lymphocytic leukaemia when compared with a chemotherapy-based…
US FDA issues 9 observations to Natco Pharma’s Kothur facility
The company said it will provide due justifications and corrective action plan within next 15 working days to address the US FDA…
Allergan reaches historic BOTOX milestone with 100 million vials
In the aesthetics market in India, BOTOX is currently licensed for the temporary improvement in moderate-to-severe glabellar lines…
Alembic Pharma gets USFDA nod for Parkinson’s disease treatment drug
The approved drug is therapeutically equivalent to the reference listed drug Sinemet CR tablets of Merck Sharp and Dohme
US FDA approves Lilly’s migraine drug as first ever cluster headache treatment
Emgality, the drug, belongs to a new class of drugs called CGRP inhibitors that are used to prevent migraines or reduce their…
Sanofi loses German patent case against Amgen over cholesterol drug
Both Praluent, manufactured by Sanofi, and Repatha by Amgen, belong to a class of PCSK9 inhibitors, used against persistently…
Karnataka govt showcases biotech innovations at BIO’19, US
Attending the largest biotechnology expo in USA, Philadelphia, the Karnataka government's delegation will also include six…
DIA India holds a conference on clinical data management and biostatistics
The overall program aimed at understanding and delving deeper into what is coming in the space of automation and utilization of…
USFDA concludes inspection of Indoco’s Sterile facility (Plant II)
The US health regulator made four observations on the pharma company's Goa plant
Aurobindo Pharma gets 10 observations from USFDA for its Unit 3 at Hyderabad
None of the observations are repetitive and are more procedural in nature, Aurobindo Pharma said
India Pharma Expo 2019 to be held in mid June in the national capital
In its 8th edition of IPE 2019, more than 100 companies are participating from all over India and abroad to display their…